trending Market Intelligence /marketintelligence/en/news-insights/trending/0t2WmwvenaNlzwlAfuPKYw2 content esgSubNav
In This List

GenMark Diagnostics begins $65M common stock offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


GenMark Diagnostics begins $65M common stock offering

GenMark Diagnostics Inc. commenced an underwritten public offering of $65 million of its common stock.

The company is selling all the shares in the offering and intends to grant the underwriters a 30-day option to purchase additional shares of up to about $9.8 million.

GenMark intends to use net proceeds for general corporate purposes and to fund its commercialization efforts.

J.P. Morgan and Bank of America Merrill Lynch are acting as joint book-running managers for the offering.